Adaptability and clinical applicability of UFS-QoL in Chinese women with uterine fibroid

Xu, Wei; Chen, Wenzhi; Chen, Jinyun; Hu, Liang; Su, Xueyao; Nie, Yuxian; Shi, Qiuling

doi:10.1186/s12905-022-01963-z

Cited by 3 publications

(6 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[14] Overall, in the present sample and the original validation study, the UFS-QoL-11 performed as well as the full version in the measures of reliability, validity, and responsiveness as the full version. [12] When comparing the correlations between the UFS-QoL and the full scale, the correlations were nearly identical. In sum, the UFS-QoL-11 scale will provide comparable information about the latent trait of symptoms and QoL for each respondent as the full scale currently does.…”

Section: Discussionmentioning

confidence: 87%

“…Overall, the test variables explained 64.46% of the total variance, which was slightly higher than the parent scale score of 63.60%. [12] Cronbach's alpha was calculated for each UFS-QoL-11 subscale to assess internal consistency. The UFS-QoL-11 questionnaire demonstrated good internal consistency and reliability for all the subscales (> 0.7).…”

Section: Resultsmentioning

confidence: 99%

“…We selected two items per UFS-QoL scale using a method that maximizes content validity. [13,24] Due to the poor internal consistency and ability to detect self-consciousness in our previous study, [12] we did not retain the three items of self-consciousness. At the same time, because sexual functioning showed poor adaptability and high correlation between the two items, we only kept one item of the two items.…”

Section: Item Selectionmentioning

confidence: 99%

“…[13,14] Our group evaluated the adaptability and clinical applicability of the Chinese UFS-QoL. [12] We found that the symptom severity, activity, and mood subscales of the Chinese UFS-QoL scale were valid and reliable. However, the self-consciousness domain exhibited poor internal consistency and detectability, we pointed out before applying the UFS-QoL to Chinese patients, the cross-cultural test criteria of adjusting the subscales to the Chinese culture, shortening or deleting the poor discrimination items to ensure the scale validity, and further optimizing and reevaluating the practicability of these items, should be considered.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Development and validation the uterine fibroid symptom and quality of life short-form: based on classical test theory and modern test theory

Zhang

et al. 2023

Preprint

Self Cite

View full text Add to dashboard Cite

Objectives Previous research has shown that the self-consciousness and sexual function domain of the uterine fibroid symptom and quality of life (UFS-QoL) questionnaire exhibited poor adaptability and clinical applicability. In light of this, our objective was to develop a shorter version of the UFS-QoL questionnaire, while ensuring its reliability, validity, and clinical applicability, in order to enhance routine clinical assessments. Methods A secondary analysis was conducted on a prospective cohort study involving 20 Chinese hospitals and 2,411 Chinese women with fibroids. We employed both classical test theory (CTT) and item response theory (IRT) to select two items for each UFS-QoL subscale. In cases where inconsistencies arose from these two methods, we utilized responsiveness to identify items with a higher ability to detect change in clinical therapy. The short-form scale was evaluated for dimensionality, internal consistency reliability, and criterion and known-group validity through factor analysis, Cronbach's alpha, Spearman correlations, and independent samples t-tests. To assess the ability to detect change, we compared pre-treatment and post-treatment (6 and 12 months) scores using effect size and standardized response mean. Results Considering the poor adaptability and clinical applicability, we made the decision to remove the self-consciousness subscale and retain only one item from the sexual functioning subscale. As a result, we administered and validated the 11-item short-form version of UFS-QoL (UFS-QoL-11). UFS-QoL-11 exhibited a strong correlation with UFS-QoL in each subscale, with correlation coefficients exceeding 0.7 (all P < 0.001). Exploratory factor analysis identified three subscales (symptom severity, concern, and daily life interference) with eigenvalues > 1 for UFS-QoL-11. The test items accounted for 64.46% of the total variance, slightly higher than the parent scale score of 63.60%. UFS-QoL-11 demonstrated excellent internal consistency and reliability across all subscales (> 0.7), representing a slight improvement compared to the full UFS-QoL. Furthermore, UFS-QoL-11 exhibited sensitivity in detecting varying levels of current health status, particularly at 6 and 12 months post-surgery. The responsiveness of UFS-QoL-11 was comparable to that of UFS-QoL, with all effect sizes > 0.5, demonstrating a strong ability to detect changes. Conclusion UFS-QoL-11 performs as well as the original version, while reducing the administrative burden by 70%. We firmly believe that the implementation of the newly developed UFS-QoL-11 has the potential to facilitate widespread, accurate, timely, and sensitive monitoring in both clinical and research settings.

show abstract

Section: Discussionmentioning

confidence: 87%

Section: Resultsmentioning

confidence: 99%

Section: Item Selectionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Development and validation the uterine fibroid symptom and quality of life short-form: based on classical test theory and modern test theory

Zhang

et al. 2023

Preprint

Self Cite

View full text Add to dashboard Cite

show abstract

“…Even so, more studies are needed to demonstrate its efficacy over LEU and its safety regarding side effects. 61,62 Pre-operative administration of UPA and LEU can reduce blood loss and operative time during laparoscopic myomectomy. The duration of the preoperative treatment with UPA and LEU showed different results regarding fibroids shrinking.…”

Section: Discussionmentioning

confidence: 99%

Shifting paradigms in uterine fibroids treatment: insights from current therapeutic approaches

Vázquez Ruvalcaba,

García,

Cornejo

et al. 2023

Int J Reprod Contracept Obstet Gynecol

View full text Add to dashboard Cite

This review examined the effectiveness of ulipristal acetate (UPA) compared to leuprolide acetate (LEU) in the treatment of symptomatic uterine fibroids. The primary objective was to analyze relevant studies that investigated the improvement of symptoms, complications, alternative treatment options, and surgical outcomes for fibroids. Using the PICO format as a research approach, various aspects were compared for each treatment, including diagnostic accuracy, side effects, quality of life, and patient satisfaction measured through the Uterine fibroid symptoms and quality of life scale. UPA proved to be a safe, well-tolerated, and effective treatment option for symptomatic uterine fibroids, leading to amenorrhea and reduced heavy menstrual bleeding. On the other hand, LEU also effectively reduced fibroid size but had a higher incidence of adverse events such as hot flashes, vaginal dryness, and decreased bone density. It is crucial to consider all the aforementioned factors when selecting the most suitable treatment option for individual patients, as each treatment has its own advantages and disadvantages, including dosing requirements, side effects, endometrial changes, and their impact on treatment adherence and outcomes. Currently, there is limited evidence supporting the superiority of UPA over other drugs like LEU in short-term therapy for symptomatic uterine fibroids. Further research is necessary to establish UPA as a reliable and promising alternative. Treatment decisions should be individualized, taking into account patient comorbidities and considering both surgical and conservative approaches.

show abstract

Comparative Efficacy of Uterine Artery Embolization versus Laparoscopic Myomectomy in Treating Uterine Fibroids: A Propensity Score Matched Analysis

Wei,

Sun,

et al. 2024

Preprint

View full text Add to dashboard Cite

Objective: The aim of this study was to comparatively analyze the therapeutic effects of uterine artery embolization (UAE) and laparoscopic myomectomy (LM) on uterine fibroids to determine which treatment method is more beneficial for patients. Materials and Methods:A retrospective study was conducted on 396 patients who underwent UAE(n=153)or LM (n=243)treatment from April 2010 to September 2019. After 1:1 propensity score matching(PSM), a comparative analysis was conducted on surgical trauma magnitude, postoperative recovery time, improvement in associated symptoms and quality of life, surgical adverse events, recurrence rates, and further interventions. Results: In PSM, 66 pairs (132 patients) were successfully matched. Both treatments significantly alleviated symptoms and enhanced quality of life. Compared to the LM group, the UAE group had less intraoperative bleeding (P<0.001), a lower rate of hemoglobin decrease (P<0.001), shorter operation, postoperative, and overall hospital stays (P<0.001), and a lower postoperative recurrence rate (P<0.05), all statistically significant. Moreover, the UAE group showed notable advantages in postoperative activities (P<0.05). However, UAE patients faced higher hospitalization costs (P<0.001). Adverse event rates (7.6% vs. 9.1%) and postoperative reintervention rates (7.6% vs. 7.6%) were relatively low and not significantly different between groups (P>0.05). Conclusion: Both UAE and LM can significantly improve patient symptoms and enhance their quality of life, and both treatment methods have low rates of adverse events and reinterventions. Compared to LM, UAE treatment for uterine fibroids presents advantages such as lesstrauma, faster recovery, and lower recurrence rate,but has higher treatment costs.

show abstract

Adaptability and clinical applicability of UFS-QoL in Chinese women with uterine fibroid

Cited by 3 publications

References 36 publications

Development and validation the uterine fibroid symptom and quality of life short-form: based on classical test theory and modern test theory

Development and validation the uterine fibroid symptom and quality of life short-form: based on classical test theory and modern test theory

Shifting paradigms in uterine fibroids treatment: insights from current therapeutic approaches

Comparative Efficacy of Uterine Artery Embolization versus Laparoscopic Myomectomy in Treating Uterine Fibroids: A Propensity Score Matched Analysis

Contact Info

Product

Resources

About